Press-release for stocks related to als for adamis pharmaceuticals corporation

Prices are updated after-hours

| 25.02% | O: 0.52% H: 0.0% C: 0.0%
covid-19 treatment phase 2 als phase 2/3 covid

Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
Published: 2022-03-14 (Crawled : 12:30) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K

| 25.02% | O: 0.52% H: 0.0% C: 0.0%
covid-19 treatment als covid

Adamis Pharmaceuticals Announces Retirement of Richard C. Williams, Chairman of the Board
Published: 2022-03-04 (Crawled : 13:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K

| 16.66% | O: -3.78% H: 0.0% C: 0.0%
als ces air

| 25.83% | O: 1.62% H: 3.23% C: 1.6%
covid-19 treatment als covid enroll

Adamis Pharmaceuticals Provides Enrollment Update of Subjects in Phase 2/3 Study of Tempol for the Treatment of COVID-19
Published: 2022-02-07 (Crawled : 14:30) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K

| 27.15% | O: 3.3% H: 3.21% C: 2.43%
covid-19 treatment phase 2 als phase 2/3 covid enroll

56%

44%

INVO | $1.76 131.58% 56.82% 230M

SINT | $0.0365 59.39% 37.26% 470M

WISA 4 | $9.19 50.66% 33.7% 65M

EDBL | News | $6.73 47.91% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 640K

TCON | $2.33 36.26% 26.61% 2M

TIRX | $0.48 6.43% 24.58% 4.8M

KZIA | $0.38 30.58% 23.42% 300K

VNDA | News | $5.23 29.14% 22.56% 24M

ATNF | $1.91 29.05% 22.51% 310K

Save your searches and get alerts when important news are released.